OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacokinetic drug evaluation of mepolizumab for the treatment of severe asthma associated with persistent eosinophilic inflammation in adults
Lakshmi Kallur, Alexei Gonzalez‐Estrada, Frank Eidelman, et al.
Expert Opinion on Drug Metabolism & Toxicology (2017) Vol. 13, Iss. 12, pp. 1275-1280
Closed Access | Times Cited: 6
Lakshmi Kallur, Alexei Gonzalez‐Estrada, Frank Eidelman, et al.
Expert Opinion on Drug Metabolism & Toxicology (2017) Vol. 13, Iss. 12, pp. 1275-1280
Closed Access | Times Cited: 6
Showing 6 citing articles:
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
Paola Faverio, Giulia Bonaiti, Francesco Bini, et al.
Therapeutics and Clinical Risk Management (2018) Vol. Volume 14, pp. 2385-2396
Open Access | Times Cited: 48
Paola Faverio, Giulia Bonaiti, Francesco Bini, et al.
Therapeutics and Clinical Risk Management (2018) Vol. Volume 14, pp. 2385-2396
Open Access | Times Cited: 48
Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update
Garry M. Walsh
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 10, pp. 1237-1244
Closed Access | Times Cited: 15
Garry M. Walsh
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 10, pp. 1237-1244
Closed Access | Times Cited: 15
Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis
Pavel Novikov, N. Bulanov, Anastasiia Zykova, et al.
Clinical pharmacology and therapy (2020) Vol. 29, Iss. 2, pp. 77-83
Open Access | Times Cited: 2
Pavel Novikov, N. Bulanov, Anastasiia Zykova, et al.
Clinical pharmacology and therapy (2020) Vol. 29, Iss. 2, pp. 77-83
Open Access | Times Cited: 2
Meta-analysis of competitive antagonists in asthma treatment
Zhen Lei, Qi Luo, Weiyi Yang, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 3, pp. 3235-3246
Open Access | Times Cited: 2
Zhen Lei, Qi Luo, Weiyi Yang, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 3, pp. 3235-3246
Open Access | Times Cited: 2
Recent developments in the use of monoclonal antibodies targeting the type 2 cytokines for severe asthma treatment
Garry M. Walsh
Advances in pharmacology (2023), pp. 31-54
Closed Access
Garry M. Walsh
Advances in pharmacology (2023), pp. 31-54
Closed Access
В. Н. Хирманов, Elena F Pavlysh, Sergey Moiseev, et al.
Clinical pharmacology and therapy (2020) Vol. 29, Iss. 2
Open Access
